JPA Health appoints Ogilvy, Edelman vet as COO
Michael Sloan joined the agency this month as chief operating officer.
-
-
Vote now for your favorite creative in the MM&M Holiday Contest
Haven’t submitted your entry yet? We’ve extended the deadline until Wednesday, December 11. -
Fleishman, Havas Lynx health execs chosen to lead Cannes juries
FleishmanHillard’s Anne de Schweinitz and Havas Lynx’s Tom Richards have been named Pharma and Health & Wellness jury presidents. -
The MM&M Podcast 12.5.2019: Life sciences leadership consultant Lynn Lapierre
LaPierre joins MM&M executive editor Marc Iskowitz to discuss how the route to the top has changed in biopharma, why pharma is shedding jobs now and where the hot jobs will be going forward. -
Best Places to Work 2019: Small, midsize and large agency winners
In our second annual review of the best small, midsize and large agencies to work at, staffers tell us why their workplaces rock.
LATEST NEWS
Five things for pharma marketers to know: Friday, December 6, 2019
Biogen Alzheimer’s data shows drug benefits; House plans to vote on Nancy Pelosi’s drug price bill; Ebola vaccine stockpile to increase to 500,000 doses.
The Escalator: W2O names two board members
Plus people moves at Ashfield, Area 23 and Envision Pharma Group.
Marketing content comes to telehealth visits
Populus, a health media startup, will coordinate the airing of 15- to 60-second spots prior to and following telehealth consults.
Stigma, isolation and a generation ‘forgotten by society’: pharma marketers’ encounter with sickle-cell patients
While launches for two new sickle-cell treatments get underway, drugmakers find that their disease marketing work has just begun to scratch the surface.
Infographic: What could you buy with the $20.5 trillion Elizabeth Warren’s health plan calls for in new federal spending?
That number got many of us at MM&M thinking: What else can be bought with $20,500,000,000,000?
Five things for pharma marketers to know: Thursday, December 5, 2019
Minnesota sues Juul over teen vaping; J&J says new tests found no asbestos in baby powder; Hospital groups challenge price transparency rule.
Pipeline Report 2020: Drugs rising from R&D purgatory, new vaccines set to surge in coming year
Several candidates relegated to the R&D graveyard re-emerged from their tombs this year and now headline the pharma developmental slate for 2020.
Finn Partners acquires Paris-based Medical & Health Consulting
Medical & Health Consulting represents biopharma, health technology and medical device companies and professional medical associations.
A Day in the Life of Best Places to Work winner Heartbeat
It’s one thing to hear employees and management talk about how great a workplace’s culture is, but it’s another to view it in person. MM&M spent a day at Best Places to Work honoree Heartbeat to see what the fuss was about.
Five things for pharma marketers to know: Wednesday, December 4, 2019
Dr. Stephen Hahn’s FDA nomination advances; Alphabet CEO to step down; Local governments opting out of federal opioid lawsuit.
